Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?

Journal of Perinatology

Volumn 27, Issue 3, 2007, Pages 158-163

  Cordero, L ^a   Nankervis, C A ^a   DeLooze, D ^b   Giannone, P J ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; INDOCIN IV; INDOMETACIN; OXYGEN; STEROID; SURFACTANT; UNCLASSIFIED DRUG;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE REGULATION; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG RESPONSE; ENCEPHALOMALACIA; EXTREMELY LOW BIRTH WEIGHT; FEMALE; FREQUENCY ANALYSIS; GESTATIONAL AGE; HUMAN; INFANT; INTESTINE PERFORATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PREECLAMPSIA; PREMATURE LABOR; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SEX RATIO; STEROID THERAPY;

CEREBRAL HEMORRHAGE; COMORBIDITY; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LEUKOMALACIA, PERIVENTRICULAR; LIGATION; MALE; RETROSPECTIVE STUDIES; TOCOLYTIC AGENTS;

EID: 33847258272     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211659     Document Type: Article

References (21)

1. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: Pathophysiology and management. J Perinatol 2006; 26: S14-S18.
2. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants; a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003; 88: F464-F466.
3. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117: 1113-1121.
4. Clyman RI. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies. J Pediatr 1996; 128: 601-607.
5. Schmidt B, Davis P, Modemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth- weight infants. N Engl J Med 2001; 344: 1966-1972.
6. Darlow BA, Horwood LJ, Clemett S. Retinopathy of prematurity: Risk factors in a prospective population-based study. Paediatr Perinat Epidemiol 1992; 6: 62-80.
7. Ohlsson A, Bottu J, Govan J, Ryan ML, Fong K, Myhr T. Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus. Dev Pharmacol Ther 1993; 20: 100-106.
8. O'Donovan DJ, Baetiong A, Adams K, Chen A, O'Brien Smith E, Adams JM et al. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol 2003; 28: 286-290.
9. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006; 26: 93-99.
10. Iams JD, Creasy RK. Preterm labor and delivery In: Creasy RJ, Resnik R, Iams JD (eds). Maternal-Fetal Medicine. Principle and Practice. 5th ed. Saunders; Philadelphia, PA, 2004 pp. 623-651.
11. Papile IA, Burstein J, Burstein R, Koffler H. Incidence and evolution of the subependymal intraventricular hemorrhage: A study of infants with weights less than 1500 g. J Pediatr 1978; 92: 529-534.
12. Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr 2000; 136: 330-337.
13. Norton M, Merrill J, Cooper B, Kuller J, Clyman R. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329: 1602-1607.
14. Clyman RI, Chen YQ, Chemtob S, Mauray F, Kohl T, Varma DR et al. In utero remodeling of the fetal lamb ductus arteriosus: The role of antenatal indomethacin and a vascular zone thickness on vasa basorum proliferation, neointima formation, and cell death. Circulation 2001; 103: 1806-1812.
15. Cordero, L, Nankervis CA, Gardner D, Giannone PJ. Ihe effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. J Perinatol 2007; 27: 22-27.
16. Van Den Veyver IB, Moise KJ, Ou C, Carpenter RJ. The effect of gestational age and fetal indomethacin levels on the incidence of constriction with advancing gestational age. Am J Obstet Gynecol 1997; 177: 256-261.
17. Weiss H, Cooper B, Brook M, Schlueter M, Clyman R. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 1995; 127: 466-471.
18. Clyman RI, Chan CY, Mauray F, Chen YQ, Cox W, Seidner SR et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia and gestation. Pediatr Res 1999; 45: 19-29.
19. Trus T, Winthrop AL, Pipe S, Shah J, Langer JC, Lau GYP. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg 1993; 28: 1137-1139.
20. Fujii AM, Brown E, Mirochnick M, O'Brien S, Kaufman G. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patient ductus arteriosus. J Perinatol 2002; 22: 535-540.
21. Schmidt B, Asztalos EV, Roberts RS, Robertson DM, Suave RS, Whitfield MF. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months. JAMA 2003; 289: 1124-1129.